Communication in non-communicable diseases (NCDs) and role of immunomodulatory nutraceuticals in their management.

Kumar, Abhiram; Sakhare, Kalyani; Bhattacharya, Dwaipayan; Chattopadhyay, Raktim; Parikh, Purvish; Narayan, Kumar P; Mukherjee, Anubhab

Kumar, Abhiram; Sakhare, Kalyani; Bhattacharya, Dwaipayan; Chattopadhyay, Raktim; Parikh, Purvish; Narayan, Kumar P; Mukherjee, Anubhab.

Afiliação

Kumar A; Esperer Onco Nutrition Pvt. Ltd., Mumbai, India.
Sakhare K; Department of Biological Sciences, Birla Institute of Technology and Science - Pilani, Hyderabad, India.
Bhattacharya D; Department of Biological Sciences, Birla Institute of Technology and Science - Pilani, Hyderabad, India.
Chattopadhyay R; Department of Biological Sciences, Birla Institute of Technology and Science - Pilani, Hyderabad, India.
Parikh P; Esperer Onco Nutrition Pvt. Ltd., Mumbai, India.
Narayan KP; Department of Clinical Haematology, Mahatma Gandhi Medical College and Hospital, Jaipur, India.
Mukherjee A; Department of Biological Sciences, Birla Institute of Technology and Science - Pilani, Hyderabad, India.

Front Nutr ; 9: 966152, 2022.

Article em En | MEDLINE | ID: mdl-36211513

Palavras-chave

NCDs; dysbiosis; gut microbiota; immunomodulatory nutritional intervention; probiotics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Front Nutr Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Índia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google